PulseAugur
LIVE 13:39:16
ENTITY Lifang Pharmaceutical

Lifang Pharmaceutical

PulseAugur coverage of Lifang Pharmaceutical — every cluster mentioning Lifang Pharmaceutical across labs, papers, and developer communities, ranked by signal.

Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TIMELINE
  1. 2026-05-22 product_launch Lifang Pharmaceutical received approval for its Azilsartan Medoxomil Potassium tablets. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. TOOL · CL_43892 ·

    Lifang Pharmaceutical secures approval for hypertension drug

    Lifang Pharmaceutical has received approval from China's National Medical Products Administration for its Azilsartan Medoxomil Potassium tablets, indicated for treating adult primary hypertension. This marks a significa…